The status of gene vectors for the treatment of diabetes

Cell Biochemistry and Biophysics

Volumn 48, Issue 2-3, 2007, Pages 183-190

  Zaia, John A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adeno assoicated virus; Adenovirus; Gene therapy; Lentivirus; Retrovirus; Vectors

Indexed keywords

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ANIMAL; ARTICLE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LENTIVIRINAE; METHODOLOGY;

ADENOVIRIDAE; ANIMALS; DEPENDOVIRUS; DIABETES MELLITUS, TYPE 1; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; LENTIVIRUS;

EID: 34548299918     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-007-0023-8     Document Type: Article

References (42)

1. Marti, G. E., Bauer, S., Puri, R. K., & Noguchi, P. D. (1994). Regulatory review of cellular and gene therapies: An overview of the process. Transfusion Science, 15, 323-329.
2. Yechoor, V., & Chan, L. (2005). Gene therapy progress and prospects: Gene therapy for diabetes mellitus. Gene Therapy, 12, 101-107.
3. Carter, J. D., Ellett, J. D., Chen, M., Smith, K. M., Fialkow, L. B., McDuffie, M. J., Tung, K. S., Nadler, J. L., & Yang, Z. (2005). Viral IL-10-mediated immune regulation in pancreatic islet transplantation. Molecular Therapy, 12, 360-368.
4. Luo, X., Yang, H., Kim, I. S., Saint-Hilaire, F., Thomas, D. A., De, B. P., Ozkaynak, E., Muthukumar, T., Hancock, W. W., Crystal, R. G., & Suthanthiran, M. (2005). Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation, 79, 1091-1096.
5. Ou, D., Wang, X., Metzgen, D. L., James, R. F., Pozzilli, P., Plesner, A., Korneluk, R. G., Verchere, C. B., & Tingle, A. J. (2005). Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Human Immunology, 66, 274-284.
6. Han, G., Li, Y., Wang, J., Wang, R., Chen, G., Song, L., Xu, R., Yu, M., Wu, X., Qian, J., & Shen, B. (2005). Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585). Journal of Immunology, 174, 4516-4524.
7. Alam, T., & Sollinger, H. W. (2002). Glucose-regulated insulin production in hepatocytes. Transplantation, 74, 1781-1787.
8. Ber, I., Shternhall, K., Perl, S., Ohanuna, Z., Goldberg, I., Barshack, I., Benvenisti-Zarum, L., Meivar-Levy, I., & Ferber, S. (2003). Functional, persistent, and extended liver to pancreas transdifferentiation. The Journal of Biological Chemistry, 278, 31950-31957.
9. Sapir, T., Shternhall, K., Meivar-Levy, I., Blumenfeld, T., Cohen, H., Skutelsky, E., Eventov-Friedman, S., Barshack, I., Goldberg, I., Pri-Chen, S., Ben-Dor, L., Polak-Charcon, S., Karasik, A., Shimon, I., Mor, E., & Ferber, S. (2005). Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proceedings of the National Academy of Sciences of the United States of America, 102, 7964-7969.
10. Kobinger, G. P., Deng, S., Louboutin, J. P., Vatamaniuk, M., Rivera, V. M., Kian, M. M., Markmann, J. F., Clackson, T., Raper, S. E., Matschinsky, F., & Wilson, J. M. (2005). Pharmacologically regulated regeneration of functional human pancreatic islets. Molecular Therapy, 11, 105-111.
11. Lebherz, C., Maguire, A. M., Auricchio, A., Tang, W., Aleman, T. S., Wei, Z., Grant, R., Cideciyan, A. V., Jacobson, S. G., Wilson, J. M., & Bennett, J. (2005). Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor. Diabetes, 54, 1141-1149.
12. Isner, J. M., Ropper, A., & Hirst, K. (2001). VEGF gene transfer for diabetic neuropathy. Human Gene Therapy, 12, 1593-1594.
13. Mohler, E. R. 3rd, Rajagopalan, S., Olin, J. W., Trachtenberg, J. D., Rasmussen, H., Pak, R., & Crystal, R. G. (2003). Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: Safety results from a phase I trial. Vascular Medicine, 8, 9-13.
14. Diaz-Sandoval, L. J., & Losordo, D. W. (2003). Gene therapy for cardiovascular angiogenesis. Expert Opinion on Biological Therapy, 3, 599-616.
15. Chan, L., Fujimiya, M., & Kojima, H. (2003). In vivo gene therapy for diabetes mellitus. Trends in Molecular Medicine, 9, 430-435.
16. St George, J. A. (2003). Gene therapy progress and prospects: Adenoviral vectors. Gene Therapy, 10, 1135-1141.
17. Danthinne, X. (2001). Simultaneous insertion of two expression cassettes into adenovirus vectors. Biotechniques, 30, 612-616 and 618-619.
18. Alba, R., Bosch, A., & Chillon, M. (2005). Gutless adenovirus: Last-generation adenovirus for gene therapy. Gene Therapy, 12, S18-S27.
19. Raper, S. E., Yudoff, M., Chirmule, N., Gao, G. P., Nunes, F., Haskal, Z. J., Furth, E. E., Propert, K. J., Robinson, M. B., Magosin, S., Simoes, H., Speicher, L., Hughes, J., Tazelaar, J., Wivel, N. A., Wilson, J. M., & Batshaw, M. L. (2002). A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Human Gene Therapy, 13, 163-175.
20. Raper, S. E., Chirmule, N., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G. P., Wilson, J. M., & Batshaw, M. L. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Molecular Genetics and Metabolism, 80, 148-158.
21. Schnell, M. A.,Zhang, Y., Tazelaar, J., Gao, G. P., Yu, Q. C., Qian, R., Chen, S. J., Varnavski, A. N., LeClair, C., Raper, S. E., & Wilson, J. M. (2001). Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Molecular Therapy, 3, 708-722.
22. Lozier, J. N., Csako, G., Mondor, T. H., Krizek, D. M., Metzger, M. E., Costello, R., Vostal, J. G., Rick, M. E., Donahue, R. E., & Morgan, R. A. (2002). Toxicity of a first-generation adenoviral vector in rhesus macaques. Human Gene Therapy, 13, 113-124.
23. Morral, N., McEvoy, R., Dong, H., Meseck, M., Altomonte, J., Thung, S., & Woo, S. L. (2002). Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes. Human Gene Therapy, 13, 1561-1570.
24. Nemerow, G. R. (2000). Adenoviral vectors-new insights. Trends in Microbiology, 8, 391-394.
25. Ostapchuk, P., & Hearing, P. (2001). Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E. Journal of Virology, 75, 45-51.
26. van Beusechem, V. W., van Rijswijk, A. L., van Es, H. H., Haisma, H. J., Pinedo, H. M., & Gerritsen, W. R. (2000). Recombinant adenovirus vectors with knobless fibers for targeted gene transfer. Gene Therapy, 7, 1940-1946.
27. Wickham, T. J. (2003). Ligand-directed targeting of genes to the site of disease. Nature Medicine, 9, 135-139.
28. Israel, B. F., Pickles, R. J., Segal, D. M., Gerard, R. D., & Kenney, S. C. (2001). Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody. Journal of Virology, 75, 5215-5221.
29. Levy, R. J., Song, C., Tallapragada, S., DeFelice, S., Hinson, J. T., Vyavahare, N., Connolly, J., Ryan, K., & Li, Q. (2001). Localized adenovirus gene delivery using antiviral IgG complexation. Gene Therapy, 8, 659-667.
30. Nicklin, S. A., Von Seggern, D. J., Work, L. M., Pek, D. C., Dominiczak, A. F., Nemerow, G. R., & Baker, A. H. (2001). Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Molecular Therapy, 4, 534-542.
31. Parker, A. L., Fisher, K. D., Oupicky, D., Read, M. L., Nicklin, S. A., Baker, A. H., & Seymour. L. W. (2005). Enhanced gene transfer activity of peptide-targeted gene-delivery vectors. Journal of Drug Targeting, 13, 39-51.
32. Nicklin, S. A., & Baker, A. H. (2002). Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Current Gene Therapy, 2, 273-293.
33. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J. I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T. H., Le Deist, F., Fischer, A., & Cavazzana-Calvo, M. (2003). LMO-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415-419.
34. Yee, J. K., & Zaia, J. A. (2003). Prospects for gene therapy using HIV-based vectors. Somatic Cell and Molecular Genetics, 26, 159-174.
35. Schroder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529.
36. Trono, D. (2000). Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Therapy, 7, 20-23.
37. Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. Journal of Virology, 72, 9873-9880.
38. Humeau, L., et al. (2003). Initiation of a phase I clinical trial using a HIV-based lentiviral vector for the treatment of HIV/ AIDS. Molecular Therapy, 7, abstract S33.
39. Clackson, T., Yang, W., Rozamus, L. W., Hatada, M., Amara, J. F., Rollins, C. T., Stevenson, L. F., Magari, S. R., Wood, S. A., Courage, N. L., Lu, X., Cerasoli, F. Jr., Gilman, M., & Holt, D. A. (1998). Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proceedings of the National Academy of Sciences of the United States of America, 95, 10437-10442.
40. Curran, M. A., Ochoa, M. S., Molano, R. D., Pileggi, A., Inverardi, L., Kenyon, N. S., Nolan, G. P., Ricordi, C., & Fenjves, E. S. (2002). Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors1. Transplantation, 74, 299-306.
41. Gallichan, W. S., Kafri, T., Krahl, T., Verma, I. M., & Sarvetnick, N. (1998). Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Human Gene Therapy, 9, 2717-2726.
42. Ju, Q., Edelstein, D., Brendel, M. D., Brandhorst, D., Brandhorst, H., Bretzel, R. G., Brownlee, M. (1998). Transduction of nondividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia, 41, 736-739.